Verdicts genuinely change. Free email alert the moment FHLC's does — no target price to set, unlike "Alert" above.
Whether this fund clears the published standards, and the filings behind that answer. The screen runs first and nothing on the trading side can override it.
Structure, momentum, positioning and levels. Separate from the Sharia verdict above, which this side never overrides.
Fidelity MSCI Health Care Index ETF · FIDELITY COVINGTON TRUST
337 holdings
NON-COMPLIANT 24.05% of portfolio weight is in non-compliant holdings, over the 5% threshold.
337 holdings, 249 matched (96% of weight). Portfolio as of 2026-07-31, filed 2026-09-23. Source: SEC Form N-PORT.
1.31% of this portfolio’s income is non-permissible — weighted across holdings, computed over 83% of portfolio weight (214 of 337 holdings). The common approach purifies that proportion of income received — dividends — not of the position’s value. We report the ratio; what to do with it is a question for your own scholar.
72.2% compliant 0.0% questionable 24.1% non-compliant 3.6% unscreened
| Holding | Status | Weight | Every methodology, and the debt ratio behind it |
|---|---|---|---|
| MNKD MannKind Corp | NON_COMPLIANT | 0.02% | AAOIFI34.1% Usmani45.2% Dow Jones Islamic23.3% S&P Shariah24.3% MSCI Islamic45.2% MSCI Islamic M-Series24.3% FTSE Shariah43.6% |
| Azenta Inc | UNSCREENED | 0.02% | no in-house ratios for this holding |
| IART Integra LifeSciences Holdings Corp | NON_COMPLIANT | 0.02% | AAOIFI68.0% Usmani24.8% Dow Jones Islamic70.3% S&P Shariah50.6% MSCI Islamic24.8% MSCI Islamic M-Series50.6% FTSE Shariah19.8% |
| ARDX Ardelyx Inc | COMPLIANT | 0.02% | AAOIFI— Usmani— Dow Jones Islamic— S&P Shariah— MSCI Islamic— MSCI Islamic M-Series— FTSE Shariah— |
| Rapport Therapeutics Inc | UNSCREENED | 0.02% | no in-house ratios for this holding |
| COLL Collegium Pharmaceutical Inc | NON_COMPLIANT | 0.02% | AAOIFI31.8% Usmani11.4% Dow Jones Islamic21.9% S&P Shariah22.5% MSCI Islamic11.4% MSCI Islamic M-Series22.5% FTSE Shariah11.2% |
| Alphatec Holdings Inc | UNSCREENED | 0.02% | no in-house ratios for this holding |
| TSHA Taysha Gene Therapies Inc | NON_COMPLIANT | 0.02% | AAOIFI3.1% Usmani12.1% Dow Jones Islamic5.9% S&P Shariah7.4% MSCI Islamic12.0% MSCI Islamic M-Series7.4% FTSE Shariah10.5% |
| First Tracks Biotherapeutics Inc | UNSCREENED | 0.02% | no in-house ratios for this holding |
| STOK Stoke Therapeutics Inc | NON_COMPLIANT | 0.02% | AAOIFI0.1% Usmani0.7% Dow Jones Islamic0.2% S&P Shariah0.3% MSCI Islamic0.7% MSCI Islamic M-Series0.3% FTSE Shariah0.0% |
| DMRA Damora Therapeutics Inc | NON_COMPLIANT | 0.02% | AAOIFI0.0% Usmani0.0% Dow Jones Islamic0.0% S&P Shariah0.0% MSCI Islamic0.0% MSCI Islamic M-Series0.0% FTSE Shariah0.0% |
| PRCT Procept Biorobotics Corp | COMPLIANT | 0.01% | AAOIFI5.9% Usmani16.2% Dow Jones Islamic3.0% S&P Shariah3.0% MSCI Islamic16.2% MSCI Islamic M-Series3.0% FTSE Shariah10.8% |
| VIR Vir Biotechnology Inc | NON_COMPLIANT | 0.01% | AAOIFI6.1% Usmani7.7% Dow Jones Islamic8.6% S&P Shariah8.1% MSCI Islamic7.7% MSCI Islamic M-Series8.1% FTSE Shariah0.0% |
| NVAX Novavax Inc | NON_COMPLIANT | 0.01% | AAOIFI17.3% Usmani31.1% Dow Jones Islamic21.2% S&P Shariah22.9% MSCI Islamic30.5% MSCI Islamic M-Series22.9% FTSE Shariah30.5% |
| PCRX Pacira BioSciences Inc | NON_COMPLIANT | 0.01% | AAOIFI39.2% Usmani33.1% Dow Jones Islamic41.2% S&P Shariah37.5% MSCI Islamic33.1% MSCI Islamic M-Series37.5% FTSE Shariah29.2% |
| CERT Certara Inc | NON_COMPLIANT | 0.01% | AAOIFI21.1% Usmani21.6% Dow Jones Islamic19.6% S&P Shariah16.3% MSCI Islamic21.6% MSCI Islamic M-Series16.3% FTSE Shariah20.8% |
| Schrodinger Inc/United States | UNSCREENED | 0.01% | no in-house ratios for this holding |
| HTFL HeartFlow Inc | COMPLIANT | 0.01% | AAOIFI0.6% Usmani7.9% Dow Jones Islamicpass S&P Shariahpass MSCI Islamic7.9% MSCI Islamic M-Seriespass FTSE Shariah0.0% |
| AHCO AdaptHealth Corp | NON_COMPLIANT | 0.01% | AAOIFIfail Usmanifail Dow Jones Islamicfail S&P Shariahfail MSCI Islamicfail MSCI Islamic M-Seriesfail FTSE Shariahfail |
| EYPT EyePoint Inc | NON_COMPLIANT | 0.01% | AAOIFIfail Usmanifail Dow Jones Islamicpass S&P Shariahpass MSCI Islamicfail MSCI Islamic M-Seriespass FTSE Shariahfail |
| Xencor Inc | UNSCREENED | 0.01% | no in-house ratios for this holding |
| PSNL Personalis Inc | NON_COMPLIANT | 0.01% | AAOIFI2.0% Usmani11.9% Dow Jones Islamic5.7% S&P Shariah8.0% MSCI Islamic11.9% MSCI Islamic M-Series8.0% FTSE Shariah0.0% |
| AnaptysBio Inc | UNSCREENED | 0.01% | no in-house ratios for this holding |
| ZYME Zymeworks Inc | NON_COMPLIANT | 0.01% | AAOIFI1.0% Usmani4.0% Dow Jones Islamic1.2% S&P Shariah1.5% MSCI Islamic4.0% MSCI Islamic M-Series1.5% FTSE Shariah0.0% |
| CRVS Corvus Pharmaceuticals Inc | COMPLIANT | 0.01% | AAOIFI— Usmani— Dow Jones Islamic— S&P Shariah— MSCI Islamic— MSCI Islamic M-Series— FTSE Shariah— |
| ZBIO Zenas Biopharma Inc | NON_COMPLIANT | 0.01% | AAOIFI3.9% Usmani11.3% Dow Jones Islamic8.0% S&P Shariah— MSCI Islamic11.3% MSCI Islamic M-Series— FTSE Shariah11.2% |
| JBIO Jade Biosciences Inc | NON_COMPLIANT | 0.01% | AAOIFI0.0% Usmani0.1% Dow Jones Islamic0.1% S&P Shariah0.1% MSCI Islamic0.1% MSCI Islamic M-Series0.1% FTSE Shariah0.0% |
| Bicara Therapeutics Inc | UNSCREENED | 0.01% | no in-house ratios for this holding |
| Omeros Corp | UNSCREENED | 0.01% | no in-house ratios for this holding |
| MLTX MoonLake Immunotherapeutics | NON_COMPLIANT | 0.01% | AAOIFI8.0% Usmani17.7% Dow Jones Islamic4.2% S&P Shariah3.6% MSCI Islamic17.7% MSCI Islamic M-Series3.6% FTSE Shariah17.3% |
| SIBN SI-BONE Inc | COMPLIANT | 0.01% | AAOIFI5.2% Usmani17.2% Dow Jones Islamic6.2% S&P Shariah6.2% MSCI Islamic17.2% MSCI Islamic M-Series6.2% FTSE Shariah14.3% |
| GLUE Monte Rosa Therapeutics Inc | NON_COMPLIANT | 0.01% | AAOIFI4.3% Usmani5.5% Dow Jones Islamic4.5% S&P Shariah5.9% MSCI Islamic5.5% MSCI Islamic M-Series5.9% FTSE Shariah0.0% |
| IRMD iRadimed Corp | COMPLIANT | 0.01% | AAOIFI0.0% Usmani0.0% Dow Jones Islamic0.0% S&P Shariah0.0% MSCI Islamic0.0% MSCI Islamic M-Series0.0% FTSE Shariah0.0% |
| CSTL Castle Biosciences Inc | NON_COMPLIANT | 0.01% | AAOIFI3.3% Usmani6.5% Dow Jones Islamic4.7% S&P Shariah5.1% MSCI Islamic6.5% MSCI Islamic M-Series5.1% FTSE Shariah1.8% |
| PAHC Phibro Animal Health Corp | NON_COMPLIANT | 0.01% | AAOIFI43.6% Usmani45.1% Dow Jones Islamic51.7% S&P Shariah64.2% MSCI Islamic45.1% MSCI Islamic M-Series64.2% FTSE Shariah41.3% |
| ArriVent Biopharma Inc | UNSCREENED | 0.01% | no in-house ratios for this holding |
| STAA STAAR Surgical Co | COMPLIANT | 0.01% | AAOIFI3.1% Usmani7.6% Dow Jones Islamic3.1% S&P Shariah2.6% MSCI Islamic7.6% MSCI Islamic M-Series2.6% FTSE Shariah0.0% |
| NUTX Nutex Health Inc | COMPLIANT | 0.01% | AAOIFI5.2% Usmani36.0% Dow Jones Islamic9.7% S&P Shariah13.7% MSCI Islamic7.4% MSCI Islamic M-Series13.7% FTSE Shariah4.1% |
| WVE WaVe Life Sciences Ltd | NON_COMPLIANT | 0.01% | AAOIFI3.9% Usmani7.8% Dow Jones Islamic2.9% S&P Shariah3.6% MSCI Islamic7.8% MSCI Islamic M-Series3.6% FTSE Shariah0.0% |
| AVAH Aveanna Healthcare Holdings Inc | NON_COMPLIANT | 0.01% | AAOIFI42.9% Usmani63.6% Dow Jones Islamic93.6% S&P Shariah119.5% MSCI Islamic63.6% MSCI Islamic M-Series119.5% FTSE Shariah61.6% |
| TYRA Tyra Biosciences Inc | COMPLIANT | 0.01% | AAOIFI0.3% Usmani1.5% Dow Jones Islamic0.5% S&P Shariah0.6% MSCI Islamic1.5% MSCI Islamic M-Series0.6% FTSE Shariah0.0% |
| Kura Oncology Inc | UNSCREENED | 0.01% | no in-house ratios for this holding |
| HSTM HealthStream Inc | COMPLIANT | 0.01% | AAOIFI1.6% Usmani2.6% Dow Jones Islamic1.6% S&P Shariah1.7% MSCI Islamic2.6% MSCI Islamic M-Series1.7% FTSE Shariah0.0% |
| MGTX MeiraGTx Holdings plc | COMPLIANT | 0.01% | AAOIFI0.9% Usmani3.1% Dow Jones Islamic1.9% S&P Shariah2.2% MSCI Islamic3.1% MSCI Islamic M-Series2.2% FTSE Shariah0.0% |
| Geron Corp | UNSCREENED | 0.01% | no in-house ratios for this holding |
| Amphastar Pharmaceuticals Inc | UNSCREENED | 0.01% | no in-house ratios for this holding |
| Sionna Therapeutics Inc | UNSCREENED | 0.01% | no in-house ratios for this holding |
| Theravance Biopharma Inc | UNSCREENED | 0.01% | no in-house ratios for this holding |
| MAZE Maze Therapeutics Inc | COMPLIANT | 0.01% | AAOIFI4.2% Usmani11.4% Dow Jones Islamicfail S&P Shariahfail MSCI Islamic11.4% MSCI Islamic M-Seriesfail FTSE Shariah7.3% |
| Cullinan Therapeutics Inc | UNSCREENED | 0.01% | no in-house ratios for this holding |
| ABUS Arbutus Biopharma Corp | NON_COMPLIANT | 0.01% | AAOIFI0.1% Usmani0.2% Dow Jones Islamic0.1% S&P Shariah0.1% MSCI Islamic0.2% MSCI Islamic M-Series0.1% FTSE Shariah0.0% |
| LB Pharmaceuticals Inc | UNSCREENED | 0.01% | no in-house ratios for this holding |
| ANNX Annexon Inc | COMPLIANT | 0.01% | AAOIFI— Usmani— Dow Jones Islamic— S&P Shariah— MSCI Islamic— MSCI Islamic M-Series— FTSE Shariah— |
| OLMA Olema Pharmaceuticals Inc | NON_COMPLIANT | 0.01% | AAOIFI0.1% Usmani0.1% Dow Jones Islamic0.1% S&P Shariah0.1% MSCI Islamic0.1% MSCI Islamic M-Series0.1% FTSE Shariah0.0% |
| PLSE Pulse Biosciences Inc | NON_COMPLIANT | 0.01% | AAOIFI0.2% Usmani5.9% Dow Jones Islamic0.5% S&P Shariah0.6% MSCI Islamic5.9% MSCI Islamic M-Series0.6% FTSE Shariah0.0% |
| Inhibrx Biosciences Inc | UNSCREENED | 0.01% | no in-house ratios for this holding |
| JANX Janux Therapeutics Inc | NON_COMPLIANT | 0.01% | AAOIFI1.7% Usmani2.1% Dow Jones Islamic1.4% S&P Shariah1.4% MSCI Islamic2.1% MSCI Islamic M-Series1.4% FTSE Shariah0.0% |
| TLRY Tilray Brands Inc | NON_COMPLIANT | 0.01% | AAOIFI9.5% Usmani7.7% Dow Jones Islamic5.9% S&P Shariah5.0% MSCI Islamic2.4% MSCI Islamic M-Series5.0% FTSE Shariah0.4% |
| KMTS Kestra Medical Technologies Ltd | NON_COMPLIANT | 0.01% | AAOIFI5.2% Usmani22.0% Dow Jones Islamicfail S&P Shariahfail MSCI Islamic22.0% MSCI Islamic M-Seriesfail FTSE Shariah20.9% |
| Sana Biotechnology Inc | UNSCREENED | 0.01% | no in-house ratios for this holding |
| SVRA Savara Inc | NON_COMPLIANT | 0.01% | AAOIFI2.7% Usmani15.7% Dow Jones Islamic3.9% S&P Shariah4.2% MSCI Islamic15.7% MSCI Islamic M-Series4.2% FTSE Shariah15.7% |
| OPK OPKO Health Inc | NON_COMPLIANT | 0.01% | AAOIFI4.2% Usmani2.8% Dow Jones Islamic4.6% S&P Shariah4.7% MSCI Islamic2.6% MSCI Islamic M-Series4.7% FTSE Shariah0.1% |
| CTMX CytomX Therapeutics Inc | NON_COMPLIANT | 0.01% | AAOIFI0.7% Usmani1.5% Dow Jones Islamic1.3% S&P Shariah1.8% MSCI Islamic1.5% MSCI Islamic M-Series1.8% FTSE Shariah0.0% |
| CorMedix Inc | UNSCREENED | 0.01% | no in-house ratios for this holding |
| Phreesia Inc | UNSCREENED | 0.01% | no in-house ratios for this holding |
| ORIC ORIC Pharmaceuticals Inc | COMPLIANT | 0.01% | AAOIFI0.3% Usmani0.8% Dow Jones Islamic0.4% S&P Shariah0.4% MSCI Islamic0.8% MSCI Islamic M-Series0.4% FTSE Shariah0.0% |
| Arvinas Inc | UNSCREENED | 0.01% | no in-house ratios for this holding |
| PHAT Phathom Pharmaceuticals Inc | NON_COMPLIANT | 0.01% | AAOIFI55.2% Usmani123.6% Dow Jones Islamic53.0% S&P Shariah57.8% MSCI Islamic123.6% MSCI Islamic M-Series57.8% FTSE Shariah122.8% |
| SEPN Septerna Inc | NON_COMPLIANT | 0.00% | AAOIFI1.3% Usmani4.0% Dow Jones Islamic2.4% S&P Shariahfail MSCI Islamic4.0% MSCI Islamic M-Seriesfail FTSE Shariah0.0% |
| PRME Prime Medicine Inc | NON_COMPLIANT | 0.00% | AAOIFI16.8% Usmani45.2% Dow Jones Islamic21.9% S&P Shariah18.8% MSCI Islamic45.2% MSCI Islamic M-Series18.8% FTSE Shariah0.0% |
| DNA Ginkgo Bioworks Holdings Inc | NON_COMPLIANT | 0.00% | AAOIFI86.3% Usmani40.8% Dow Jones Islamic70.5% S&P Shariah31.1% MSCI Islamic40.8% MSCI Islamic M-Series31.1% FTSE Shariah0.0% |
| GDRX GoodRx Holdings Inc | NON_COMPLIANT | 0.00% | AAOIFI44.8% Usmani23.0% Dow Jones Islamic40.0% S&P Shariah32.4% MSCI Islamic23.0% MSCI Islamic M-Series32.4% FTSE Shariah20.8% |
| SPRY ARS Pharmaceuticals Inc | NON_COMPLIANT | 0.00% | AAOIFI17.3% Usmani38.7% Dow Jones Islamic8.7% S&P Shariah9.8% MSCI Islamic38.7% MSCI Islamic M-Series9.8% FTSE Shariah38.7% |
| EMBC Embecta Corp | NON_COMPLIANT | 0.00% | AAOIFI467.7% Usmani118.7% Dow Jones Islamic228.0% S&P Shariah214.9% MSCI Islamic116.2% MSCI Islamic M-Series214.9% FTSE Shariah115.0% |
| Chicago Mercantile Exchange | UNSCREENED | 0.00% | no in-house ratios for this holding |
| Capricor Therapeutics Inc | UNSCREENED | 0.00% | no in-house ratios for this holding |
| UPB Upstream Bio Inc | NON_COMPLIANT | 0.00% | AAOIFI0.3% Usmani0.3% Dow Jones Islamic0.1% S&P Shariah— MSCI Islamic0.3% MSCI Islamic M-Series— FTSE Shariah0.0% |
| Compass Therapeutics Inc | UNSCREENED | 0.00% | no in-house ratios for this holding |
| EVMN Evommune Inc | NON_COMPLIANT | 0.00% | AAOIFI1.7% Usmani2.9% Dow Jones Islamicfail S&P Shariahfail MSCI Islamic2.5% MSCI Islamic M-Seriesfail FTSE Shariah0.0% |
| Chicago Mercantile Exchange | UNSCREENED | 0.00% | no in-house ratios for this holding |
| CONTRA AKOUOS INC | UNSCREENED | 0.00% | no in-house ratios for this holding |
| OABI OMNIAB INC | NON_COMPLIANT | 0.00% | AAOIFI3.0% Usmani6.5% Dow Jones Islamic5.9% S&P Shariah4.7% MSCI Islamic6.5% MSCI Islamic M-Series4.7% FTSE Shariah0.0% |
| CONTRA HOLOGIC INCORPO | UNSCREENED | 0.00% | no in-house ratios for this holding |
| OABI OMNIAB INC | NON_COMPLIANT | 0.00% | AAOIFI3.0% Usmani6.5% Dow Jones Islamic5.9% S&P Shariah4.7% MSCI Islamic6.5% MSCI Islamic M-Series4.7% FTSE Shariah0.0% |
| CONTRA CHINOOK THERAPE | UNSCREENED | 0.00% | no in-house ratios for this holding |
| CONTRA AKERO THERAPEUT | UNSCREENED | 0.00% | no in-house ratios for this holding |
| CONTRA ARCELLX INC | UNSCREENED | 0.00% | no in-house ratios for this holding |
The published standards disagree about this fund by 31 points of portfolio weight — 70.9% of it passes AAOIFI, 39.7% passes MSCI Islamic. Which number is yours depends on which standard you follow.
These bars are the financial-ratio result under each standard — debt, receivables and interest income. They do not screen what the business does, so a holding can pass every ratio here and still be questionable or non-compliant on activity. The blended verdict above accounts for both.
ratios pass on 70.9% ratios fail on 15.9% 13.1% not rated under AAOIFI
ratios pass on 43.5% ratios fail on 42.5% 13.9% not rated under Usmani
ratios pass on 68.1% ratios fail on 18.3% 13.5% not rated under Dow Jones Islamic
ratios pass on 69.7% ratios fail on 16.7% 13.5% not rated under S&P Shariah
ratios pass on 39.7% ratios fail on 48.4% 11.8% not rated under MSCI Islamic
ratios pass on 68.9% ratios fail on 17.5% 13.4% not rated under MSCI Islamic M-Series
ratios pass on 44.8% ratios fail on 41.2% 13.9% not rated under FTSE Shariah
248 of 337 listed holdings carry our own per-methodology verdicts (96% of weight). The rest hold a provider verdict with no methodology breakdown, and are counted as rated by none. Of those, 221 (83% of weight) also carry the underlying debt ratio; the rest show a verdict without the figure behind it.
| Non-compliant holding | Weight |
|---|---|
| UNH UnitedHealth Group Inc | 5.44% |
| PFE Pfizer Inc | 2.06% |
| BMY Bristol-Myers Squibb Co | 1.93% |
| CVS CVS Health Corp | 1.92% |
| ELV Elevance Health Inc | 1.19% |
| CI Cigna Group/The | 1.06% |
| HCA HCA Healthcare Inc | 0.91% |
| BDX Becton Dickinson & Co | 0.68% |
| HUM Humana Inc | 0.63% |
| IQV IQVIA Holdings Inc | 0.58% |
Methodology breakdown computing — it will appear here on its own.
Whether the technical picture shows an edge right now. Separate from the Sharia verdict, which this side never overrides.
The factors behind the read, each shown with the figure it rests on, including the ones pointing the other way.
Fidelity MSCI Health Care Index ETF (FHLC) is currently considered not halal (non-compliant), per our own look-through to its filed holdings. See its filed holdings and the weight breakdown below for the reasoning.
Computing the full ratio and business-activity breakdown for FHLC — this runs off the critical path so the page paints first. It will appear here on its own.
| Investor | Firm | Position | Weight | As of |
|---|---|---|---|---|
| Ken Fisher | Fisher Asset Management | $1M | 0.0% | 2026-06-30 |
From the most recent 13F on file. A 13F reports long US equity positions quarterly and in arrears — it is what a manager held on the report date, not what they hold today.
Pinch or scroll to zoom · drag to pan — both axes move · double-click to reset
Classic floor-trader pivots from the last completed daily bar. Highlighted pills are the levels bracketing the current price.
The range is measured volatility (ATR over the horizon), not a target — a wider band means a more volatile asset, not a stronger view. The direction is the indicator tally below. Every forecast is recorded when made and scored against the real price when it comes due, including the wrong ones. Not a recommendation, and not a fatwa.
Standard indicator thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20, MACD histogram sign, price vs. average) computed on daily bars. A summary of what common indicators say — not a recommendation, and not this site's own trading verdict.
| Indicator | Value | Signal |
|---|---|---|
| RSI (14) | 61.90 | NEUTRAL |
| Stochastic %K (14) | 80.40 | SELL |
| CCI (20) | 214.10 | SELL |
| Williams %R (14) | -19.60 | SELL |
| MACD (12,26,9) | 0.34 | BUY |
| ROC (10) | 4.90 | BUY |
| Momentum (10) | 3.95 | BUY |
| EMA (10) | 82.99 | BUY |
| SMA (10) | 82.49 | BUY |
| EMA (20) | 82.45 | BUY |
| SMA (20) | 82.22 | BUY |
| EMA (30) | 82.16 | BUY |
| SMA (30) | 81.86 | BUY |
| EMA (50) | 81.47 | BUY |
| SMA (50) | 82.22 | BUY |
| EMA (100) | 79.45 | BUY |
| SMA (100) | 79.13 | BUY |
| EMA (200) | 76.61 | BUY |
| SMA (200) | 75.56 | BUY |
The fund invests at least 80% of assets in securities included in the fund's underlying index. The fund's underlying index is the MSCI USA IMI Health Care 25/50 Index, which represents the performance of the health care sector in the U.S. equity market. It may or may not hold all of the securities in the MSCI USA IMI Health Care 25/50 Index. The fund is non-diversified.
Background via Yahoo Finance — informational, not part of the verdict.
Weak — low conviction, small size or skip
Market structure by timeframe, read from real bars. A bias per timeframe rather than a forecast — timeframes disagreeing is information, not noise.
| Timeframe | Bias | Bars |
|---|---|---|
| 📅 Daily | BULLISH | 42 |
| ⏰ 4H | BULLISH | 34 |
| 🕐 1H | BULLISH | 98 |
| ⏱ 15-Min | BEARISH | 130 |
| ⏲ 5-Min | BULLISH | 234 |
Rate of change and relative volume against this symbol's own recent history. Momentum describes what price has done; it is not a claim about what it will do.
How the rest of the sector moved over the same window. Context for a price move, never a cause of one.
Peer movement computing — it will appear here on its own.
The questions worth asking about any verdict on this page, answered plainly.
No. HTR reads the fund's filed holdings and screens each one, then reports the result by weight. A fund marketed as Islamic still gets the same look-through as any other.
It is the share of the fund whose holdings HTR cannot cover far enough to rate. It is reported as unrated rather than counted as compliant, because a holding nobody screened should not look like one that passed.
It matters, and it is noted, but it does not replace the look-through. The board's judgement and the holdings screen are shown separately so you can see when they agree and when they do not.
When the fund files new holdings, and on a rolling basis besides. The date on the verdict above is the last time this fund was actually recomputed.
Open research, not a fatwa. HTR applies published screening standards to filings and publishes what they say, including when they disagree. Nothing here is financial advice or a recommendation to buy or sell. Verdicts can change when new filings land.
Same screen, different answers. Comparison is where the standards disagreeing becomes useful rather than confusing.
Peer screening computing — it will appear here on its own.
Insider transactions reported in the last ninety days. Insiders sell for reasons that have nothing to do with a view, so a sale on its own is not a signal.
NO DATA 0 buys · 0 sells
The weekly CFTC Commitments of Traders report for the broad market it tracks, not for this symbol. Positioning context for the tape — it says nothing about this company.
NEUTRAL report date 2026-10-13 · Asset managers net 915835 (+9220)
Plain-language summary of the evidence already on this page — the Sharia screen, structure, momentum, and order flow above. It explains the read; it doesn't make the call. Generated on demand (a live AI call), never run automatically.